![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, March 02, 2011 3:04:47 PM
(I'm reasonably certain that the SEC inquiry has been escalated to a non-public investigation. I exchanged several emails with the investigator myself. What convinces me, though, is that Jussayinn speaks with the investigator by phone at least once a week.)
My purpose in posting on the POSC boards is to persuade others to complain to SEC and provide any tips they can if they believe, as I do, that the events of April/May were a pump-and-dump--which is against the law.
In order to do this, I must persuade you that the company has made 'false and misleading statements', that it's sales projection are impossible to meet, and that it has failed to inform investors of important information. I always try to be fair to the company however.
Example: there is language in Positron's filings indicating a risk of radiopharmaceutical supply shortages which could adversely effect business. I can't deny that.
Yet the company's failure so far to publicly address the current Cardiogen shortage is irresponsible. Also, I'm reasonably certain that Rooney could forsee the shortage, although I no longer believe he had actual advance knowledge of the timing.
On the other hand, it's possible that one reason Positron recently has contracted with a professional IR firm is to navigate the next several months of the Cardiogen shortage. CSIR, like any good IR firm, includes 'crisis communication' in it's portfolio of services.
And make no mistake about it, the Cardiogen shortage is a crisis for Positron! This situation is roughly equivalent to what the BP oil-rig explosion was for BP.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM